The Valley Desk

NCT05005728 · Interventional trial

XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer

Overall registry status Completed

Phase 2

Conditions Metastatic Castration-Resistant Prostate Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov